Live Chat

Les CFD sont des instruments complexes et sont accompagnés d’un risque élevé de pertes financières rapides en raison de l’effet de levier. 76,3 % des comptes d’investisseurs particuliers perdent de l’argent en tradant des CFD avec ce fournisseur. Vous devez déterminer si vous comprenez comment fonctionnent les CFD et si vous pouvez vous permettre de courir le risque élevé de perdre votre argent.

Close

Tradez Thermo Fisher TMO

 Graphique en direct de ThermoFisher

Informations

Weekly Search
Weekly
Daily
date Fermer change % Variation Ouvrir un compte Haut Bas

instr__news

Webhose 2024 Dec 04, 12:07

Thermo Fisher achève un rachat d'actions d'un milliard de dollars Par Investing.com

Thermo Fisher Scientific Inc

Markets.com news

man writing inflation on line charts
Alec Malloy 2024 Aug 19, 16:05

Test News Article French Only

BoJ Matières premières
French election results to drive European markets
markets.com Support Team 2024 Jul 04, 21:00

Semaine à venir : Les résultats des élections françaises sont déterminants pour les marchés européens

Le Forex Indices
Macron calls snap election, riles markets
markets.com Support Team 2024 Jun 29, 21:00

Semaine à venir : La France va-t-elle déclencher une crise de l'euro ?

CPI
Businessman pointing hologram online banking icon.
markets.com Support Team 2024 Jun 20, 16:00

Semaine à venir : Beaucoup de données et d'informations sur l'inflation

Le Forex Indices

Info

Spread

3.38

Spread (%)

0.6398 %

Effet de levier

1:5

Intérêt au jour le jour à l’achat

-0.0597 %

Intérêt au jour le jour à la vente

-0.0292 %

Devise

USD

Horaires de Trading

Markets closed

Mardi

14:31 - 20:59

Lundi

14:31-20:59

Mercredi

14:31-20:59

Jeudi

14:31-20:59

Vendredi

14:31-20:59

Compte de résultat

Ouvrir un compte

---

Fermeture précédente

---

Plus haut/plus bas des 52 dernières semaines

--- – ---

Capitalisation boursière

200923414528

Actions en circulation

382500000

Date de rapport d'activité (suivante)

1996-06-06

instr__dividend_date

2025-01-15

instr__ex_dividend_date

2024-12-13

instr__forward_annual_dividend_rate

1.56

instr__forward_annual_dividend_yield

0.003

EPS

15.97

Actions en circulation

Thermo Fisher Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. It has a collaboration agreement with Mainz Biomed N.V. for the development of colorectal cancer screening product. Thermo Fisher Scientific Inc. was founded in 1956 and is headquar

En savoir plus sur cet instrument

Actif
Vendre
Acheter
% Variation
Instruments connexes
Trustpilot
Live Chat